Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Supervised vs Unsupervised CQ-PQ for P. Vivax Malaria
NCT07753967Completed
- Sponsor
- Jimma University
- Start
- Dec 2024
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Randomised, open-label trial of chloroquine and primaquine in malaria (2 arms), sponsored by Jimma University. Primary endpoints: Recrudescent Rate at 42 days and Parasitic Clearance at 42 days. Started Dec 2024; status: completed.
02
Drugs
chloroquineprimaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT07753967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07753967.